BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11029847)

  • 1. Case study using descriptive analysis to estimate hidden costs in processing third party prescriptions.
    Herrier RN; Spencer JR; Davis CD
    J Am Pharm Assoc (Wash); 2000; 40(5):658-65. PubMed ID: 11029847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
    Murry L; Gerleman B; Urick B; Urmie J
    J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profitability, third-party reimbursement, and access to community pharmacies.
    Carroll NV; Miederhoff PA; Waters LW
    Clin Ther; 1996; 18(4):703-15; discussion 702. PubMed ID: 8879898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating pharmacy level prescription drug acquisition costs for third-party reimbursement.
    Kreling DH; Kirk KW
    Med Care; 1986 Jul; 24(7):590-600. PubMed ID: 3523065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing changes in third-party gross margin for a single community pharmacy.
    Urick BY; Urmie JM; Doucette WR; McDonough RP
    J Am Pharm Assoc (2003); 2014; 54(1):27-34. PubMed ID: 24362541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of costs to dispense prescriptions in independently owned, closed-door long-term care pharmacies.
    Carroll NV; Rupp MT; Holdford DA
    J Manag Care Spec Pharm; 2014 Mar; 20(3):291-300. PubMed ID: 24564809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of the additional costs of dispensing workers' compensation prescriptions.
    Schafermeyer KW
    Res Social Adm Pharm; 2007 Mar; 3(1):123-36. PubMed ID: 17350561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating a reasonable reimbursement for community pharmacies in third-party programs.
    Carroll NV
    Manag Care Interface; 1999 Feb; 12(2):73-6, 79-80. PubMed ID: 10346189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a change in third party reimbursement rate on prescription gross margin.
    Ganther JM; Kreling DH
    J Am Pharm Assoc (Wash); 1999; 39(3):346-52. PubMed ID: 10363461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negotiating with third party payers: one community pharmacy's experience.
    Fridy K; DeHart RM; Monk-Tutor MR
    J Am Pharm Assoc (Wash); 2002; 42(5):780-8. PubMed ID: 12269712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the cost of unclaimed electronic prescriptions at an independent pharmacy.
    Doucette WR; Connolly C; Al-Jumaili AA
    J Am Pharm Assoc (2003); 2016 Jan; 56(1):58-61. PubMed ID: 26802922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating the impact of Medicare part D on the profitability of independent community pharmacies.
    Carroll NV
    J Manag Care Pharm; 2008 Oct; 14(8):768-79. PubMed ID: 18983206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a budget-impact model to quantify potential cost savings from prescription opioids designed to deter abuse or ease of extraction.
    White AG; Birnbaum HG; Rothman DB; Katz N
    Appl Health Econ Health Policy; 2009; 7(1):61-70. PubMed ID: 19558195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of insurance type with costs of dispensed drugs.
    Mott DA; Kreling DH
    Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of generic and therapeutic interchange incentives on community pharmacy.
    Carroll NV
    Am Pharm; 1995 Jul; NS35(7):27-34. PubMed ID: 7661103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microcost analysis of the prescription dispensing process in an outpatient hospital pharmacy.
    Hatoum HT; Hutchinson RA; Elliott LR; Eck TA
    Am J Hosp Pharm; 1988 Jun; 45(6):1328-33. PubMed ID: 3414700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National observational study of prescription dispensing accuracy and safety in 50 pharmacies.
    Flynn EA; Barker KN; Carnahan BJ
    J Am Pharm Assoc (Wash); 2003; 43(2):191-200. PubMed ID: 12688437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third party payment policies: design & impact.
    Schondelmeyer SW
    Am Pharm; 1986 Aug; NS26(8):41-5, 48-56, 63-8. PubMed ID: 3776831
    [No Abstract]   [Full Text] [Related]  

  • 19. Who cares what it costs to dispense a Medicaid prescription?
    Lamphere-Thorpe JA; Johnston WP; Kilpatrick KE; Norwood GJ
    Health Care Financ Rev; 1994; 15(3):9-24. PubMed ID: 10137800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing the delivery of pharmacy services.
    Miller MJ; Ortmeier BG
    Am Pharm; 1995 Jan; NS35(1):39-45. PubMed ID: 7887373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.